Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Bone Diseases, Metabolic

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffith, JF; Leung, PC; Lv, H; Ma, HT; Yeung, DK; Zhao, X1

Trials

1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Bone Diseases, Metabolic

ArticleYear
Relationship between marrow perfusion and bone mineral density: a pharmacokinetic study of DCE-MRI.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2012, Volume: 2012

    Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Diseases, Metabolic; Bone Marrow; Contrast Media; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Osteoporosis; Perfusion

2012